TABLE 2 

Female-male mortality risk ratio in RTS,S malaria vaccine recipients

Age groupFemale/male risk ratio (95% CI)
R3RaR3CbR3R and R3C combined
5–17 mo1.38 (0.84–2.29)1.65 (0.94–2.90)1.50 (1.03–2.18)
6–12 wk1.18 (0.69–2.03)1.18 (0.70–1.98)1.18 (0.81–1.72)
 
Total1.33 (1.02–1.74)
  • a R3R, 3× RTS,S plus booster RTS,S.

  • b R3C, 3× RTS,S plus comparator vaccine.